Where your CBAM exposure actually lives

The EU Carbon Border Adjustment Mechanism, CBAM, moved into its definitive phase on 1 January 2026. The European Commission CBAM guidance describes this as the phase where authorised declarants move towards embedded-emissions declarations and CBAM certificate surrender.

The cash effect builds in stages. The first certificate sales are expected in 2027, while 2026 imports already create the data and liability trail that later gets declared. The practical issue for a UK exporter is timing. The customer may ask for product-level emissions evidence before the exporter sees a certificate invoice, because the EU importer carries the formal obligation and needs usable data from its supplier.

That makes CBAM a sales, procurement and finance issue in the same moment. A product with two tonnes of embedded CO2e per tonne and a certificate price near EUR75 per tonne has a gross carbon-cost input of around EUR150 per tonne before free-allocation adjustments, product scope and contract treatment are considered. The number can look small in the early phase and still be material when the customer uses it to renegotiate price, ask for verified data, or switch supplier.

Why we used a value-chain exposure map.

A value-chain exposure map is a simple management tool for locating where value, cost and risk enter a product system. It is common in strategy and operations work because it stops the business treating a problem as a single departmental task.

That is the right lens for CBAM. The formal declaration may sit with the EU importer, but the commercial exposure enters through supplier data, material choices, production records, customer contracts, logistics documents and finance assumptions. For this Signal Note, we used the map to ask one question: where can CBAM change margin before the business has treated it as a price item?

For the evergreen Shield route into this kind of decision, see market exposure and response readiness.

What the exposure map shows.

Exposure point 1: supplier data decides whether the customer trusts the cost.

The UK business guidance on EU CBAM says EU importers may ask UK manufacturers and suppliers for emissions data and evidence of carbon prices already paid. The useful management implication is clear. Supplier emissions evidence now sits inside customer account management. If procurement cannot obtain usable data, sales may inherit the discount request.

Exposure point 2: default values can become a pricing penalty.

Where verified actual emissions are missing, importers may need to use default values. That can make a low-data supplier look more expensive than a higher-data supplier with similar physical product cost. The risk is commercial rather than only regulatory. The EU customer may price the uncertainty into the next tender.

Exposure point 3: downstream product scope is moving closer to engineered goods.

The original CBAM scope focused on carbon-intensive goods such as iron and steel, aluminium, cement, fertilisers, hydrogen and electricity. The research trail also points to policy momentum around downstream products that contain steel or aluminium. That matters for UK manufacturers whose own operations are relatively clean but whose bill of materials carries imported metal exposure.

Exposure point 4: finance needs a cash-timing view alongside the unit-cost view.

CBAM creates quarterly and annual control points for importers. Even where the payable factor is small in the early phase, the business still needs to know which products create a future liability, who owns the calculation and how customer pass-through will work.

Exposure point 5: UK CBAM creates a second control layer.

The GOV.UK UK CBAM policy summary sets out the UK's own CBAM plan. For UK manufacturers, the point is that carbon-border accounting is becoming part of normal trade administration. A business that sells into the EU and buys carbon-intensive inputs needs one view across EU customer requests and UK import exposure.

The management application.

The useful board view is product-line based. Start with the EU-facing products that contain CBAM-covered inputs or metals with uncertain emissions data. For each product, show the supplier, material, country of origin, data status, customer request history, contract pass-through and finance sensitivity.

The board needs a product-level control view: which products can defend their margin under customer scrutiny, and which ones depend on assumptions nobody can evidence.

What to do before the next EU tender.

1. List EU-facing products that contain steel, aluminium, cement, fertiliser, hydrogen or electricity inputs.
2. Map the supplier data available for each input, including emissions factors and carbon-price evidence.
3. Ask sales which EU customers have already requested CBAM or product-carbon information.
4. Check whether contracts allow pass-through of carbon-related cost changes.
5. Build one finance sensitivity at product level, using material share, emissions intensity and likely customer treatment.
6. Decide which product lines need supplier evidence work before the next renewal or tender.

Red flags.

• CBAM sits only in a compliance update.
• Procurement owns supplier data, sales owns the customer promise, and finance owns the margin model in separate files.
• EU customers have asked for emissions evidence and the response depends on a manual spreadsheet.
• The business knows the direct emissions from its own site but cannot evidence upstream material emissions.
• Contract renewals assume carbon costs can be passed through without written terms.

Torsik read.

CBAM is a value-chain margin test. The businesses with the better customer position will be the ones that can show, by product line, where the carbon exposure enters, how the data is controlled and how the margin is protected.

Treat the next EU customer request as a readiness test. If the answer takes more than a day to assemble, the exposure is already operational.

Boundary. This is a commercial framework. Company-specific trade, tax, customs, regulatory, legal or financial treatment needs current official guidance, product codes, supplier evidence, customer terms and specialist review.